Tema Obesity & Cardiometabolic ETF Rating $29.15 +0.08 (+0.28%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Tema Obesity & Cardiometabolic ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.79Holdings in HRTS have an aggregate rating of Moderate Buy based on 498 analyst ratings issued in the past year covering 38 companies (86.7% of the portfolio).HRTS Aggregate Price Target$29.15High Prediction$29.15Average Prediction$29.15Low Prediction$29.15Holdings in HRTS have an aggregate price target of $29.15 and a range of $29.15 to $29.15 covering 38 companies (86.7% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Obesity & Cardiometabolic ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.91%LLYEli Lilly and Company$767.76+1.3%4.9933 of 5 stars2.81$1,002.22 30.5%21Gap UpHigh Trading Volume5.51%VRTXVertex Pharmaceuticals$397.27+0.2%4.7494 of 5 stars2.52$499.77 25.8%31Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume4.93%ALNYAlnylam Pharmaceuticals$245.44+2.8%4.416 of 5 stars2.71$298.09 21.5%24Analyst Upgrade4.23%BBIOBridgeBio Pharma$26.49+1.1%4.6915 of 5 stars2.86$47.69 80.0%14High Trading Volume4.08%CRNXCrinetics Pharmaceuticals$53.60+1.6%4.0769 of 5 stars3.00$74.40 38.8%10Positive NewsHigh Trading Volume3.65%AMGNAmgen$263.38+0.8%4.4625 of 5 stars2.40$319.67 21.4%25Analyst DowngradeGap UpHigh Trading Volume3.45%ASNDAscendis Pharma A/S$136.38-1.0%3.1319 of 5 stars2.92$191.77 40.6%133.25%CYTKCytokinetics$48.87+4.6%4.1475 of 5 stars2.75$84.07 72.0%16Analyst Forecast3.12%BSXBoston Scientific$88.95+0.3%4.2542 of 5 stars2.91$95.96 7.9%23Analyst ForecastHigh Trading Volume2.80%DXCMDexCom$80.04+5.6%4.9177 of 5 stars2.72$98.00 22.4%18High Trading Volume2.72%MDTMedtronic$81.03+1.3%4.9162 of 5 stars2.41$95.00 17.2%17Analyst ForecastOptions Volume2.63%MASIMasimo$169.52-0.3%3.5743 of 5 stars2.71$175.67 3.6%7Analyst Forecast2.54%MREOMereo BioPharma Group$3.35+1.8%2.0953 of 5 stars3.33$7.40 120.9%6High Trading Volume2.49%IONSIonis Pharmaceuticals$35.63+0.1%4.4264 of 5 stars2.68$60.65 70.2%19Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume2.47%MIRMMirum Pharmaceuticals$41.51+0.9%4.0055 of 5 stars3.09$57.10 37.6%11Positive NewsHigh Trading Volume2.42%KROSKeros Therapeutics$17.03+0.7%3.3039 of 5 stars2.71$81.33 377.6%14High Trading Volume2.37%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6604 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume2.16%EWEdwards Lifesciences$74.81+1.2%3.8612 of 5 stars2.42$79.40 6.1%26High Trading Volume2.05%GPCRStructure Therapeutics$27.90-6.9%2.3688 of 5 stars3.00$86.50 210.0%7Analyst ForecastNews CoverageGap UpHigh Trading Volume2.03%MLYSMineralys Therapeutics$12.34+4.3%2.6968 of 5 stars3.00$30.00 143.1%3News CoveragePositive NewsHigh Trading Volume1.99%PODDInsulet$266.57+3.9%4.2495 of 5 stars2.80$269.40 1.1%15Positive News1.89%ARWRArrowhead Pharmaceuticals$19.45-0.3%4.3731 of 5 stars2.64$42.70 119.5%11Analyst ForecastInsider TradeNews CoverageHigh Trading Volume1.77%RAREUltragenyx Pharmaceutical$44.22+1.7%4.4487 of 5 stars2.92$88.46 100.0%13Analyst ForecastNews CoverageHigh Trading Volume1.64%RCKTRocket Pharmaceuticals$11.56+1.9%4.8532 of 5 stars2.92$48.80 322.1%12Analyst ForecastHigh Trading Volume1.56%NTLAIntellia Therapeutics$12.18+0.8%4.2319 of 5 stars2.72$54.94 351.0%18High Trading Volume1.50%MDGLMadrigal Pharmaceuticals$308.44+5.1%4.2404 of 5 stars2.69$347.33 12.6%13Positive News1.36%WSTWest Pharmaceutical Services$331.40+1.3%4.9652 of 5 stars2.80$437.75 32.1%5High Trading Volume1.34%VKTXViking Therapeutics$42.25+1.8%4.2992 of 5 stars3.15$106.75 152.7%13Analyst ForecastGap Up1.32%AKROAkero Therapeutics$29.34+3.3%4.094 of 5 stars2.88$46.83 59.6%8Insider Trade1.16%NARIInari Medical$55.45+1.9%3.3165 of 5 stars2.50$61.80 11.5%12Analyst ForecastInsider Trade0.88%EWTXEdgewise Therapeutics$30.78-0.1%2.7186 of 5 stars3.00$43.17 40.2%6Analyst ForecastAnalyst Revision0.84%SLNOSoleno Therapeutics$45.180.0%4.4765 of 5 stars3.14$74.83 65.6%7High Trading Volume0.79%TNYATenaya Therapeutics$1.67+18.4%3.9001 of 5 stars3.00$17.33 937.9%6Analyst ForecastNews CoverageHigh Trading Volume0.76%VERVVerve Therapeutics$5.74+11.2%1.9742 of 5 stars3.00$25.75 348.6%4High Trading Volume0.72%TERNTerns Pharmaceuticals$5.86-3.1%4.2467 of 5 stars2.80$18.30 212.3%5High Trading Volume0.62%SLNSilence Therapeutics$6.88+8.5%3.1687 of 5 stars3.00$57.20 731.4%6High Trading Volume0.49%CRBPCorbus Pharmaceuticals$13.00-2.5%3.7007 of 5 stars3.11$62.00 376.9%90.25%RANIRani Therapeutics$1.40+7.7%3.4564 of 5 stars3.14$11.71 736.7%7Positive News This page (NYSEARCA:HRTS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts